Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan K Davis

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Implementation Science : IS|August 16, 2023
Implementing traumatic brain injury screening in behavioral health treatment settings: results of an explanatory sequential mixed-methods investigationKathryn A Hyzak, Alicia C Bunger, Jennifer Bogner, et al.
Psychopharmacology|December 12, 2019
Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgmentMalin V Uthaug, Rafael Lancelotta, Attila Szabo, et al.
Journal of Affective Disorders|December 30, 2022
Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptomsAki Nikolaidis, Rafaelle Lancelotta, Natalie Gukasyan, et al.
BMJ Open|May 4, 2023
Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSDAlan K Davis, Adam W Levin, Paul B Nagib, et al.
Translational Issues in Psychological Science|May 8, 2018
Why do young people consume marijuana? Extending motivational theory via the Dualistic Model of PassionAlan K Davis, Brooke J Arterberry, Erin E Bonar, et al.
Psychopharmacology|May 18, 2026
Correction to: Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgmentMalin V Uthaug, Rafael Lancelotta, Attila Szabo, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug EffectsJacob S Aday, Alan K Davis, Cayla M Mitzkovitz, et al.
Neuroscience and Biobehavioral Reviews|March 21, 2020
Long-term effects of psychedelic drugs: A systematic reviewJacob S Aday, Cayla M Mitzkovitz, Emily K Bloesch, et al.
Implementation Science Communications|February 15, 2022
Implementing traumatic brain injury screening in behavioral healthcare: protocol for a prospective mixed methods studyKathryn A Coxe-Hyzak, Alicia C Bunger, Jennifer Bogner, et al.
Journal of Psychopharmacology (Oxford, England)|May 16, 2019
Cessation and reduction in alcohol consumption and misuse after psychedelic useAlbert Garcia-Romeu, Alan K Davis, Fire Erowid, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Implementation Science : IS|August 16, 2023
Implementing traumatic brain injury screening in behavioral health treatment settings: results of an explanatory sequential mixed-methods investigationKathryn A Hyzak, Alicia C Bunger, Jennifer Bogner, et al.
Psychopharmacology|December 12, 2019
Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgmentMalin V Uthaug, Rafael Lancelotta, Attila Szabo, et al.
Journal of Affective Disorders|December 30, 2022
Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptomsAki Nikolaidis, Rafaelle Lancelotta, Natalie Gukasyan, et al.
BMJ Open|May 4, 2023
Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSDAlan K Davis, Adam W Levin, Paul B Nagib, et al.
Translational Issues in Psychological Science|May 8, 2018
Why do young people consume marijuana? Extending motivational theory via the Dualistic Model of PassionAlan K Davis, Brooke J Arterberry, Erin E Bonar, et al.
Psychopharmacology|May 18, 2026
Correction to: Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgmentMalin V Uthaug, Rafael Lancelotta, Attila Szabo, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug EffectsJacob S Aday, Alan K Davis, Cayla M Mitzkovitz, et al.
Neuroscience and Biobehavioral Reviews|March 21, 2020
Long-term effects of psychedelic drugs: A systematic reviewJacob S Aday, Cayla M Mitzkovitz, Emily K Bloesch, et al.
Implementation Science Communications|February 15, 2022
Implementing traumatic brain injury screening in behavioral healthcare: protocol for a prospective mixed methods studyKathryn A Coxe-Hyzak, Alicia C Bunger, Jennifer Bogner, et al.
Journal of Psychopharmacology (Oxford, England)|May 16, 2019
Cessation and reduction in alcohol consumption and misuse after psychedelic useAlbert Garcia-Romeu, Alan K Davis, Fire Erowid, et al.
Pageof 10